Orbimed Advisors
Asset Manager SEC-registered adviser
Legal name: Orbimed Advisors LLC
AUM
$20.6B
Regulatory AUM
Private funds
24
Other 14 · Hedge Fund 5 · Private Equity 5
Private fund assets
$19.0B
Gross asset value
Employees
118
Last Form D raise
May 2026
Most recent fund filing
From SEC Form ADV filing (filed Aug 18, 2026). View on SEC
Investment focus
As listed in industry directories; may be out of date.
- Stages
- Series A
- Geographies
- USACanada
People(8)
Owners and executive officers named on the firm's SEC Form ADV.
Funds(24)
Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.
| Fund | Type | Gross assets | Raised (Form D) | Investors | Last Form D | Recency |
|---|---|---|---|---|---|---|
| Orbimed Asia Partners VI, LP | Other | $684.8M | $534.0M | 45 | May 2026 | Hot |
| Orbimed Private Investments X, LP | Other | $1.6B | $1.7B | 119 | Apr 2026 | Hot |
| Orbimed Genesis Master Fund, L.P. | Hedge Fund | $747.0M | $145.9M | 20 | Apr 2026 | Warm |
| Orbimed Royalty & Credit Opportunities V, LP | Private Equity | $1.1B | $1.2B | 52 | May 2025 | Cool |
| Orbimed Royalty & Credit Opportunities V Offshore, LP | Private Equity | $788.6M | $1.2B | 31 | May 2025 | Cool |
| Orbimed Private Investments IX, LP | Other | $2.2B | $1.8B | 141 | Apr 2023 | Cold |
| Orbimed New Horizons Master Fund, L.P. | Hedge Fund | $13.6M | $61.6M | 55 | Apr 2023 | Cold |
| Orbimed Royalty & Credit Opportunities IV, LP | Private Equity | $1.4B | $1.2B | 113 | Dec 2022 | Cold |
| Orbimed Royalty & Credit Opportunities IV Offshore, LP | Private Equity | $567.9M | $344.5M | 18 | Dec 2022 | Cold |
| Orbimed Asia Partners V, LP | Other | $947.9M | $651.9M | 68 | Nov 2022 | Cold |
| Orbimed Private Investments VIII, LP | Other | $1.7B | — | — | Aug 2020 | Cold |
| Orbimed Royalty & Credit Opportunities III, LP | Private Equity | $359.1M | $889.8M | 69 | Jul 2019 | Cold |
| Orbimed Private Investments VII, LP | Other | $1.1B | — | — | Jan 2018 | Cold |
| Orbimed Asia Partners III, L.P. | Other | $2.1B | $540.0M | 97 | Sep 2017 | Cold |
| Orbimed Israel Partners II, L.P. | Other | $298.5M | — | — | Dec 2015 | Cold |
Board seats(6)
Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.
Shares boards with
Firms whose people sit on the same company boards.
Regulatory identifiers
- CRD number
- 118608
- SEC file number
- 801-61046
- CIK
- 1055951
Sources
- SEC Form ADV Oct 14, 2026